Table 2. Univariate and multivariate analysis of factors influencing the primary outcome (death) in cancer patients affected with COVID-19.
| Variables | Subcategories | Death*, n (%) | P value | |||
|---|---|---|---|---|---|---|
| Yes (n=64) | No (n=246) | Univariate analysis | Multivariate analysis | |||
| Sex | Males | 27 (19.01) | 115 (80.99) | 0.514 | 0.919 | |
| Females | 37 (22.02) | 131 (77.98) | ||||
| Age >60 years | Yes | 12 (34.29) | 23 (65.71) | 0.034 | 0.656 | |
| No | 52 (18.91) | 223 (81.09) | ||||
| Type | Breast | 7 (25.00) | 21 (75.00) | 0.000178 | 0.001 | |
| GI and HPB | 21 (36.84) | 36 (63.16) | ||||
| Gynaecological | 6 (17.14) | 29 (82.86) | ||||
| Head and neck | 5 (12.20) | 36 (87.80) | ||||
| Hematology | 18 (28.57) | 45 (71.43) | ||||
| Others | 7 (18.42) | 31 (81.58) | ||||
| Routine | 0 | 48 (100.00) | ||||
| Hypertension | Yes | 44 (54.32) | 37 (45.68) | 0.0028 | 0.474 | |
| No | 20 (8.73) | 209 (91.27) | ||||
| Diabetes mellitus | Yes | 50 (60.24) | 33 (39.76) | 0.0927 | 0.683 | |
| No | 14 (6.17) | 213 (93.83) | ||||
| Chemotherapy | Yes | 52 (46.02) | 61 (53.98) | 0.3098 | 0.019 | |
| No | 12 (6.09) | 185 (93.91) | ||||
| Symptomatic | Yes | 6 (21.43) | 22 (78.57) | 0.0016 | 0.780 | |
| No | 48 (18.25) | 215 (81.75) | ||||
| SOB | 10 (52.63) | 9 (47.37) | ||||
| Place of treatment | Home | 12 (7.02) | 159 (92.98) | <0.0001 | 0.761 | |
| Hospital | 52 (37.41) | 87 (62.59) | ||||
| Oxygen/intervention required | Yes | 22 (75.86) | 7 (24.14) | <0.0001 | 0.021 | |
| No | 0 | 230 (100.00) | ||||
| Intervention | 42 (82.35) | 9 (17.65) | ||||
*, figures included in columns with parenthesis indicates frequency percentage. COVID-19, coronavirus disease 2019; GI, gastrointestinal; HPB, hepato-pancreato-biliary; SOB; shortness of breath.